Purchases and Sales Made in Q4 2023 in Ngm Biopharmaceuticals Inc (NGM)
This table provides information about the institutional ownership of Ngm Biopharmaceuticals Inc (NGM) during Q4 2023. The information is specifically focused on institutions that hold shares of NGM BIOPHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-16.2K- 97.69% |
$9.73K - $21.2K
|
384
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-16.2K- 58.13% |
$9.73K - $21.2K
|
11.7K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-34.2K- 77.23% |
$20.5K - $44.8K
|
10.1K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-41.4K- 25.69% |
$24.8K - $54.2K
|
120K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-48.6K- 58.06% |
$29.1K - $63.6K
|
35.1K
$0
|
|
|
Feb 12, 2024
Q4 2023
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-48.7K- 41.38% |
$29.2K - $63.8K
|
69K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-52.9K- 48.15% |
$31.7K - $69.3K
|
57K
$0
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-53.4K- 25.71% |
$32.1K - $70K
|
154K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-80K- 29.09% |
$48K - $105K
|
195K
$0
|
|
|
Feb 05, 2024
Q4 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-80.5K- 64.88% |
$48.3K - $105K
|
43.6K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-92K- 56.03% |
$55.2K - $120K
|
72.2K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-134K- 91.52% |
$80.2K - $175K
|
12.4K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-163K- 59.51% |
$97.6K - $213K
|
111K
$0
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-240K- 41.02% |
$144K - $315K
|
345K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Jasper Ridge Partners, L.P.
Menlo Park, CA |
SELL
|
- |
-284K- 93.66% |
$171K - $372K
|
19.3K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-317K- 66.38% |
$190K - $415K
|
160K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-662K- 17.23% |
$397K - $867K
|
3.18M
$0
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.39M- 98.0% |
$831K - $1.82M
|
28.3K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-4.05M- 62.93% |
$2.43M - $5.31M
|
2.39M
$0
|